Displaying 1 - 10 of 19 articles
Pharmaceutical giant Pfizer has engaged in a series of paper transactions to create a A$936 million loss in Australia – effectively a billion-dollar exercise in avoiding tax.
Drug prices in Australia are three times higher than in New Zealand. A key reason is the lack of transparency about taxpayer subsidies for Big Pharma and the companies' own finances.
How much can a multinational take before its social licence to operate in this country expires? How much corporate welfare is too much?
The Australian government took out ads this month boasting of victory in the fight against multinational tax avoidance. It is no small irony that taxpayers forked out for this bald-faced lie.
Federal Resources Minister Matt Canavan is not only espousing a A$1 billion taxpayer leg-up for Indian coal magnate Gautam Adani to build a rail line but has now called for public money to be deployed…
The NSW Business Chamber insists that arguing against entitlements for low-paid workers and victims of domestic violence qualifies as a charitable exercise.
Australian authorities have allowed predatory online travel agents to shrink their tax base while penalising Australian accommodation operators thanks to onerous commissions and vanishing competition
If the government were to provide loan insurance or loan guarantees, the banks might be more inclined to fund Adani. Taxpayers would then be at risk for the estimated $10 billion in project finance.
Health insurance is yet another sector that is subsidised by taxpayers yet whose financial disclosures are murky to the point of deception.
The Senate Inquiry into Corporate Tax Avoidance has heard stunning evidence about the failure of the tax and royalties system to capture any of the billions being generated by new projects.